Research Group on Healthcare Service and Collaboration is currently working on three sub-projects:

RESEARCH RESULTS

  1. Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up. European Journal of Preventive Cardiology (EJPC) supplement, 2026. Conference abstract.
  2. Individually Tailored monitoring at home after hospitalization for HEART failure (IT-HEART): Design and baseline characteristics of a randomized clinical trial.European Journal of Preventive Cardiology (EJPC) supplement, 2026. Conference abstract.
  3. Patient- and healthcare system predictors of participation in a municipal smoking cessation programme after hospitalisation for atherosclerotic cardiovascular disease. European Journal of Preventive Cardiology (EJPC) supplement, 2026. Conference abstract.
  4. Patient- and healthcare system predictors of participation in a municipal smoking cessation programme after hospitalisation for atherosclerotic cardiovascular disease. V Getz (presenter), K Pleym, T Dammen, E Husebye, E Sverre, Peersen, C Papageorgiou, H Weedon-Fekjær, and J Munkhaugen. Poster presentation/conference abstract, ESC Preventive Cardiology Congress 2026, Ljubljana, Slovenia.
  5. Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up. Karin Pleym (presenter), Ingrid Engebretsen, Elise Sverre, Toril Dammen, Einar Huseby, Mohpal Singh Kahlon, Marie Stugaard, Henrik Støvring, Ivar Sønbø Kristiansen, and John Munkhaugen. Poster presentation/conference abstract, ESC Preventive Cardiology Congress 2026, Ljubljana, Slovenia.
  6. Individually Tailored monitoring at home after hospitalization for HEART failure (IT-HEART): Design and baseline characteristics of a randomized clinical trial Heart Failure Reviews, 2026.
  7. Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up. Addiction, 2026.
  8. Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials. Tobacco Prevention & Cessation, 2026.
  9. Motivational smoking cessation counselling and community-based follow-up after hospitalisation for vascular disease:  a randomised controlled trial. Addiction, 2025
  10. A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease. A randomized trial.European Heart Journal Open, 2024
  11. Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial – a qualitative study. Frontiers in Psychology vol 14, 2023
  12. Effect of in-hospital nurse-led smoking cessation intervention for patients with atherosclerotic cardiovascular disease: a randomised pilot study. European Heart Journal 2022.